1. Paulin, Denise, Hovhannisyan, Yeranuhi, Kasakyan, Serdar, Li, Zhenlin, Xue, Zhigang. 2020. Synemin-related skeletal and cardiac myopathies: an overview of pathogenic variants. In American journal of physiology. Cell physiology, 318, C709-C718. doi:10.1152/ajpcell.00485.2019. https://pubmed.ncbi.nlm.nih.gov/32023076/
2. Chen, Siyu, Wu, Yong, Wang, Simin, Wu, Xiaohua, Zheng, Zhong. 2022. A risk model of gene signatures for predicting platinum response and survival in ovarian cancer. In Journal of ovarian research, 15, 39. doi:10.1186/s13048-022-00969-3. https://pubmed.ncbi.nlm.nih.gov/35361267/
3. Zhang, Shu-Bing, Liu, Yu-Xing, Fan, Liang-Liang, Jin, Jie-Yuan, Xiang, Rong. 2018. A novel heterozygous variant p.(Trp538Arg) of SYNM is identified by whole-exome sequencing in a Chinese family with dilated cardiomyopathy. In Annals of human genetics, 83, 95-99. doi:10.1111/ahg.12287. https://pubmed.ncbi.nlm.nih.gov/30276801/
4. Russell, Mary A. 2020. Synemin Redefined: Multiple Binding Partners Results in Multifunctionality. In Frontiers in cell and developmental biology, 8, 159. doi:10.3389/fcell.2020.00159. https://pubmed.ncbi.nlm.nih.gov/32258037/
5. Swärd, Karl, Krawczyk, Katarzyna K, Morén, Björn, Stenkula, Karin, Rippe, Catarina. 2019. Identification of the intermediate filament protein synemin/SYNM as a target of myocardin family coactivators. In American journal of physiology. Cell physiology, 317, C1128-C1142. doi:10.1152/ajpcell.00047.2019. https://pubmed.ncbi.nlm.nih.gov/31461342/
6. Noetzel, E, Rose, M, Sevinc, E, Knüchel, R, Dahl, E. 2010. Intermediate filament dynamics and breast cancer: aberrant promoter methylation of the Synemin gene is associated with early tumor relapse. In Oncogene, 29, 4814-25. doi:10.1038/onc.2010.229. https://pubmed.ncbi.nlm.nih.gov/20543860/
智鼠故事 
